Editorial: The New York Times

• The U.S. Supreme Court rejected a challenge to the most commonly used abortion drug, mifepristone, but only on procedural grounds, not considering the merits of the lawsuit.
• Despite mifepristone being effective and safe, abortion opponents keep pushing for its ban.
• The Court stated that doctors opposing abortion don't have the grounds to challenge FDA's approval of the drug just because they disagree with it.
• Despite the support that the majority of Americans have for decades shown towards abortion rights, anti-abortion lawmakers keep finding ways to subvert this voice.
• Access to the abortion pill is preserved for the time being, but this is a narrow procedural win for reproductive rights.

Conclusion: If one values a woman's right to control what happens in her own body, it's time to worry about another challenge to mifepristone that might reach the Supreme Court.

---